What is Iboga? – All About the Mysterious Plant from West Africa

Iboga - a name that has gained increasing attention in recent years. But what exactly is Iboga?

The root bark of the West African plant Tabernanthe iboga is considered a "teacher plant" in many cultures, said to induce deep insights, spiritual experiences, and intense states of consciousness.

While it has been used in rituals in its native Gabon and Cameroon for centuries, the Western world is now also interested in its psychedelic effects and its potential therapeutic properties – especially in addiction treatment, trauma therapy, and psychotherapy.

In the following article, we explain what Iboga actually is, what makes the plant so special, and what incredible potentials scientists from medicine and psychology, as well as pharmaceutical companies, are currently researching. Enjoy reading!

Note: All described content is based on scientific sources or subjective experience reports and is not to be understood as instructions or recommendations for the consumption of Iboga.

The Iboga plant, native to Africa, became particularly well known through its use in the so-called Bwiti tradition – a spiritual practice that combines elements of nature religion, healing arts, and philosophy. In Gabon, Iboga is considered sacred: it is used in initiation rites to promote spiritual clarity, healing, and a deeper connection with the self.

For the production of ritual Iboga, the root bark of the plant is ground into powder or chopped into small pieces and then consumed orally. The Iboga root is thus the most important part of the plant.

In Europe, Iboga is available both as a tincture and as capsules.

Tabernanthe iboga, often abbreviated simply as Iboga, Eboga, or Obona, is an evergreen shrub that naturally grows in the shade of the undergrowth of the tropical rainforests of Central Africa. The plant belongs to the dogbane family and can grow up to 4 meters tall.

In some areas of West Africa, the shrub is now even cultivated specifically due to the sharply increased demand for Iboga root bark.

In the Bwiti tradition, Iboga is not regarded as a drug, but as a sacred sacrament. During nocturnal ceremonies, initiates consume the root bark, accompanied by music, dance, and spiritual chants.

The goal is the purification of the spirit, expanded consciousness, the processing of old traumas, and a deeper connection with one's soul. These rituals often last several hours and are led by experienced healers.

The main active ingredient of Iboga is Ibogaine, an alkaloid that acts on the central nervous system. Scientific studies show that Ibogaine targets several neurotransmitter systems - including serotonin, dopamine, and NMDA receptors. This can trigger altered states of consciousness, as well as emotional and physical processes. In higher doses, Iboga can act as a hallucinogen and exhibit psychedelic properties.

Particularly in Western research, Ibogaine is being investigated for its potential benefit in the treatment of drug addiction, depression, consequences of trauma , and other addiction-related disorders.

In addition to scientific studies, the internet also contains numerous experience reports from individuals who have explored the Iboga root through their own experiments.

According to user reports, Iboga can have the following effects:

• Increased well-being

• Increased energy and focus

• Mood enhancement

• Strengthening neuroprotective processes

• Breaking addictions

• Stress reduction

• Expanded consciousness

• More mental clarity

In recent decades, Iboga - more precisely, the ibogaine derived from it - has attracted scientific interest.

Researchers and pharmaceutical companies are investigating the extent to which ibogaine could be supportive in the treatment of addictions such as heroin, alcohol, or cocaine dependence and in opioid withdrawal.

Initial studies indicate that ibogaine could alleviate withdrawal symptoms and reduce cravings for substances. Nevertheless, the mechanism of action remains complex and treatment should be left to professional medical practitioners.

Further scientific studies provide results suggesting that ibogaine could mitigate the psychological symptoms typically associated with depression, pathological anxiety, post-traumatic stress disorder (PTSD), and other post-traumatic conditions.

Iboga and its main active ingredient Ibogaine are currently in a legal grey area in Germany. Neither the plant Tabernanthe iboga nor the contained active ingredient ibogaine are currently listed in the Narcotics Act (BtMG) or the NpSG. This means: The possession and consumption of Iboga or Ibogaine is, as of now, not expressly prohibited.

However, ibogaine and iboga are not approved in Germany as either a medicine or a food product and are therefore not subject to any medical or food law controls. According to the current legal situation, doctors are not legally permitted to use ibogaine for therapeutic purposes, for example, to treat addictions or in people with depression.

There is no verified information, safety instructions or official recommendations regarding suitable dosages, only personal reports and case studies from people who have conducted their own tests with iboga.

The iboga shrub is emblematic of the connection between ancient wisdom and modern research. While the iboga plant is revered as a spiritual teacher in Africa, pharmacologists and other modern researchers are looking for ways to safely and responsibly harness its potential for therapies and help patients with this substance.

Whether as an instrument of healing, awareness or self-knowledge – iboga remains a fascinating plant at the intersection of nature, religion, culture and medicine.

• Cherian K., Shinozuka K., Tabaac B.J., Arenas A., Beutler B.D., Evans V.D., Fasano C., Muir O.S.(2024). Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01;31(2):e133-e140. doi: 10.1097/MJT.0000000000001723 

• Vonk, G. J. A., Leeuwenberg, A. J. M.: A taxonomic revision of the genus Tabernanthe and a study of wood anatomy of T. iboga. In: Wageningen Agric. Univ. Papers. 89–4, 1989, Series of revisions of Apocynaceae. XXIX, pp. 1–18, online (PDF).

• Köck P., Froelich K., Walter M., Lang U., Dürsteler K.M. (2022). A systematic literature review of clinical trials and therapeutic applications of ibogaine. J Subst Abuse Treat. 2022 Jul;138:108717. doi: 10.1016/j.jsat.2021.108717